# Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela

> **NCT02283879** · PHASE1 · UNKNOWN · sponsor: **Shenzhen Hornetcorn Bio-technology Company, LTD** · enrollment: 20 (estimated)

## Conditions studied

- Cerebral Hemorrhage

## Interventions

- **BIOLOGICAL:** Human umbilical cord mesenchymal stem cells

## Key facts

- **NCT ID:** NCT02283879
- **Lead sponsor:** Shenzhen Hornetcorn Bio-technology Company, LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2016-12
- **Final completion:** 2017-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02283879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02283879, "Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02283879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*